Ju‐Hong Min

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder

Ju‐Hong Min, Byoung Joon Kim, Kwang Ho Lee · Multiple Sclerosis Journal · 2011 · 282 citations

Extensive Brain Lesions, Ophthalmology, Scleroderma +13

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders

So‐Young Huh, Ju‐Hong Min, Woojun Kim et al. · Multiple Sclerosis Journal · 2013 · 84 citations

Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea

Jin Myoung Seok, Hye-Jin Cho, Suk-Won Ahn et al. · Multiple Sclerosis Journal · 2017 · 75 citations · Full text